Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia

This study has been completed.
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00155337
First received: September 8, 2005
Last updated: December 20, 2012
Last verified: December 2012
  Purpose

Photodynamic therapy for oral leukoplakia and erythroleukoplakia


Condition Intervention Phase
Oral Leukoplakia
Procedure: photodynamic therapy
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia

Resource links provided by NLM:


Further study details as provided by National Taiwan University Hospital:

Primary Outcome Measures:
  • End of 8 treatments

Secondary Outcome Measures:
  • Regression of lesions

Estimated Enrollment: 40
Study Start Date: August 2004
Study Completion Date: December 2007
Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)
Detailed Description:

Photodynamic therapy for oral leukoplakia and erythroleukoplakia

  Eligibility

Ages Eligible for Study:   20 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients with leukoplakia or erythroleukoplakia

Exclusion Criteria:

  • oral cancers
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00155337

Locations
Taiwan
National Taiwan University Hospital
Taipei, Taiwan, 100
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Principal Investigator: Chun-Pin Chiang, DMSc National Taiwan University Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00155337     History of Changes
Other Study ID Numbers: 9361700753
Study First Received: September 8, 2005
Last Updated: December 20, 2012
Health Authority: Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:
leukoplakia
erythroleukoplakia
photodynamic therapy

Additional relevant MeSH terms:
Leukoplakia, Oral
Leukoplakia
Mouth Neoplasms
Head and Neck Neoplasms
Neoplasms by Site
Neoplasms
Precancerous Conditions
Mouth Diseases
Stomatognathic Diseases
Pathological Conditions, Anatomical

ClinicalTrials.gov processed this record on October 19, 2014